S&P 500 Industrials Sector SEC Filings — April 08, 2026

08-04-2026

Shattuck Labs, Inc. has filed definitive additional proxy materials (DEFA14A) for its Annual Meeting of Stockholders on May 28, 2026, at 11:30 AM Eastern Time, held live via the internet at www.proxydocs.com/STTK. Key proposals include electing three Class III directors (Taylor Schreiber, M.D., Ph.D., Helen M. Boudreau, and Clay Siegall, Ph.D.) to serve until the 2029 Annual Meeting, ratifying KPMG LLP as independent auditors for the year ending December 31, 2026, an advisory vote to approve named executive officer compensation, an advisory vote on the frequency of future say-on-pay votes (Board recommends 1 year), and approving an amendment and restatement of the 2020 Equity Incentive Plan. Stockholders of record as of April 2, 2026, can access full materials online or request paper copies by May 18, 2026.

• ·Board recommends voting 'FOR' each director nominee in Proposal 1, 'FOR' Proposals 2, 3, and 5, and '1 YEAR' on Proposal 4.
• ·Proxy materials available at www.proxydocs.com/STTK; requires 12-digit control number to vote or register.
• ·No fee required for filing; paper requests via www.investorelections.com/STTK, 1-866-648-8133, or paper@investorelections.com.

08-04-2026

RPM International Inc. reported record Q3 FY26 net sales of $1.61 billion, up 8.9% YoY driven by 3.0% organic growth, acquisitions, and 2.4% foreign currency benefits, with adjusted EBIT reaching a record $116.4 million (+48.8% YoY) and adjusted diluted EPS of $0.57 (+62.9% YoY). However, net income declined 1.3% to $51.4 million and diluted EPS remained flat at $0.40, while the Consumer Group experienced a 2.4% organic sales decline amid soft DIY demand. All segments posted sales growth (CPG +10.5%, PCG +8.4%, Consumer +7.9%), and the company reaffirmed Q4 FY26 guidance for mid-single-digit sales growth and low- to high-single-digit adjusted EBIT growth; it also completed the Kalzip acquisition.

• ·9M FY26 cash from operations $656.7M, second-highest ever, up from $619.0M prior year.
• ·9M FY26 capital expenditures $159.6M vs. $158.9M prior year.
• ·Returned $255.3M to stockholders in 9M FY26 via dividends and repurchases, +5.2% YoY.
• ·Q3 asset sales proceeds $14.3M from MAP initiatives.
• ·Revolving credit facility extended to Feb 27, 2031, size $1.35B.
• ·Kalzip acquisition closed March 31, 2026, added to Construction Products Group.

08-04-2026

E Fund Management (Hong Kong) Co., Ltd. filed its 13F-HR on April 8, 2026, reporting U.S. equity holdings as of March 31, 2026, with all positions held under sole voting power and no shared or other voting authority indicated. The portfolio features large positions in ETFs and tech stocks, including iShares Core S&P 500 ETF ($29.0B), Apple Inc ($7.2B), Amazon.com Inc ($4.6B), Broadcom Inc ($4.2B), and Meta Platforms Inc ($3.7B). No period-over-period changes or performance metrics are disclosed in this snapshot filing.

• ·All holdings reported with sole voting power (SH SOLE) and zero shared or other voting authority
• ·Portfolio includes positions in over 250 U.S.-listed issuers across sectors like technology, mining, healthcare, and ETFs
• ·SEC file number: 028-20248
• ·Business address: Suites 3501-02, 35/F Two International Finance Centre, Central, K3 852, Hong Kong

08-04-2026

Day One Biopharmaceuticals, Inc. filed Amendment No. 1 to its Schedule 14D-9 on April 8, 2026, announcing that the FTC granted early termination of the HSR Act waiting period on April 7, 2026, at 1:37 p.m. Eastern Time, thereby satisfying the antitrust condition for Servier Detroit Inc.'s cash tender offer to purchase all outstanding shares at $21.50 per share. The offer, pursuant to the March 6, 2026 Merger Agreement, remains subject to other conditions in the Offer to Purchase dated March 26, 2026. No negative developments or unmet conditions are reported in this amendment.

• ·Premerger Notification and Report Forms filed with FTC and Antitrust Division on March 26, 2026
• ·Merger Agreement dated March 6, 2026
• ·Offer to Purchase dated March 26, 2026

08-04-2026

Venture Global, Inc. filed Definitive Additional Proxy Materials (DEFA14A) with the SEC on April 08, 2026. This filing supplements prior proxy statements pursuant to Section 14(a) of the Securities Exchange Act of 1934. No specific proposals, financial data, or governance details are provided in the filing header.

• ·Filing Type: DEFA14A (Definitive Additional Materials)
• ·Filed by the Registrant

08-04-2026

Emergent Wealth Advisors, LLC filed its 13F-HR report on April 8, 2026, for the quarter ended March 31, 2026, disclosing 125 equity holdings all managed with sole investment discretion and sole voting authority. The portfolio features significant ETF positions including BlackRock iShares Flexible Income ETF (135,950 shares), iShares Core MSCI EAFE ETF (112,158 shares), and iShares Core MSCI Emerging Markets ETF (111,567 shares), alongside stocks such as NVIDIA Corporation (11,556 shares) and Amazon.com Inc. (8,978 shares). No prior period comparisons, performance metrics, or shared authority positions were reported.

• ·Business address: 5500 Main St., Suite 260, Williamsville, NY 14221
• ·Phone: 716-828-8390
• ·SEC file number: 028-25810
• ·Value qualifier: 0 (discretionary AUM under $100 million)
• ·All positions reported as sole discretion with no put/call options or other voting authority

08-04-2026

rYojbaba Co., Ltd. (RYOJ) filed a Form 20-F/A amendment to its annual report for the fiscal year ended December 31, 2025, on April 8, 2026. The filing includes newly filed exhibits such as Sarbanes-Oxley Act certifications by the CEO and CFO (Exhibits 12.1, 12.2, 13.1), a Clawback Policy (Exhibit 97.1), and Inline XBRL documents (Exhibits 101.* and 104). Other exhibits, including agreements and policies, are incorporated by reference from prior filings.

• ·Signed by Takayuki Nakano on April 7, 2026.
• ·References prior filings: Form 6-K on August 15, 2025; Form F-1 on August 2, 2024; Form 6-K on March 4, 2026; Form 20-F on March 23, 2026.

08-04-2026

Ausbil Investment Management Ltd filed its 13F-HR report on April 8, 2026, disclosing $201,000,898 in discretionary holdings across 63 positions as of March 31, 2026. Top holdings include H2O America ($14,275,840), NextEra Energy Inc ($13,096,864), and CSX Corp ($10,820,398), with a focus on utilities, energy, transportation, and industrials. The portfolio includes long positions and put options on BHP Group Ltd (40,000 shares), Freeport-McMoRan Inc (50,000 shares), and VanEck Gold Miners ETF (20,000 shares).

• ·Put options: BHP Group Ltd (value 12000, 40000 shares), Freeport-McMoRan Inc (value 22000, 50000 shares), VanEck Gold Miners ETF (value 8000, 20000 shares)
• ·All positions reported as SOLE ownership
• ·Report filed for period ending 2026-03-31

08-04-2026

Longboard Asset Management, LP reported 28 equity holdings totaling $5,787,788 as of March 31, 2026, in its 13F-HR filing. The portfolio features top positions in utilities such as Alliant Energy Corporation ($252,739 value, 3,522 shares), Aflac Inc. ($252,552 value, 2,302 shares), and FirstEnergy Corporation ($252,236 value, 4,979 shares), alongside multiple REITs including InvenTrust Properties Corp ($230,643, 7,572 shares). All holdings are with sole voting power and no reported shared discretion.

• ·Filing date: April 08, 2026
• ·Report period end: March 31, 2026
• ·All 28 positions held with sole voting power (SH SOLE); no shared power or other managers reported
• ·Portfolio heavily weighted toward utilities and REITs

08-04-2026

Corebridge Financial has entered a definitive all-stock merger agreement with Equitable Holdings to create a leading retirement, life, wealth, and asset management company with over 12 million customers and $1.5 trillion in assets under management and administration. The merger is expected to enhance capabilities for CREI by leveraging AllianceBernstein’s global distribution, with closure targeted by year-end 2026 subject to regulatory and shareholder approvals. While the transaction offers potential synergies and scale, it carries significant risks including integration challenges, failure to obtain approvals, business disruptions, and potential adverse impacts on operations and stock price.

• ·Transaction to close by year-end 2026, subject to customary closing conditions including regulatory approvals and shareholder votes.
• ·Corebridge and Equitable to operate separately until closing, with no changes to CREI partner contacts.
• ·Forward-looking statements highlight risks such as integration difficulties, failure to realize synergies, business disruptions, and potential rating downgrades.

08-04-2026

Boltwood Capital Management disclosed $392,066,630 in total equity holdings across 184 positions in its 13F-HR filing as of March 31, 2026. The portfolio features heavy allocations to ETFs including FlexShares iBoxx 3R Target ($21.9M), various iShares Treasury and international equity funds, SPDR sector ETFs, and individual names such as Apple ($9.6M), NVIDIA ($9.4M), and Microsoft ($7.1M). No period-over-period changes are available in this filing.

• ·Report period end: March 31, 2026
• ·Filing date: April 8, 2026
• ·All holdings reported as sole discretionary (SH SOLE)

08-04-2026

Abacus Planning Group, Inc. disclosed its quarterly 13F-HR holdings totaling $742,886,732 across 264 positions as of March 31, 2026, all held with sole voting and discretionary power. Top holdings include ETF Ser Solutions Distillate US Fund at $82,956,949 (11.2% of portfolio), iShares TR 0-5 YR TIPS ETF at $62,294,699, and Amazon.com Inc. at $19,463,665. The portfolio features heavy allocations to ETFs (e.g., Dimensional, Schwab Strategic, iShares) including Bitcoin, gold, silver, and fixed income products, alongside individual stocks like Apple Inc. ($13,898,799).

• ·Filing submitted April 8, 2026, for period ending March 31, 2026.
• ·All 264 positions held as sole discretionary accounts with sole voting power.
• ·Notable exposure to commodities/alt assets: Sprott Physical Silver ($13,786,813), Sprott Physical Gold ($6,056,164), iShares Silver TR ($963,568).

08-04-2026

Central Pacific Bank - Trust Division filed Form 13F-HR on April 08, 2026, disclosing 970 equity holdings as of March 31, 2026, with a total portfolio value of $783638357. The portfolio features positions in major companies including Apple Inc. (5868072065 shares defined), Alphabet Inc., Amazon.com Inc., and hundreds of others across sectors like technology, healthcare, and consumer goods. This is a routine quarterly holdings report with no explicit period-over-period changes detailed.

• ·Filing date: April 08, 2026
• ·Period end date: March 31, 2026
• ·State of incorporation: HI
• ·Fiscal year end: 12/31
• ·SEC file number: 028-24090
• ·Contact phone: 8085446808

08-04-2026

Deep Isolation Nuclear, Inc. announced its selection for the U.S. Department of Energy’s ARPA-E SCALEUP Ready program to advance commercial deployment of its Universal Canister System for nuclear waste management, with the program committing up to $40 million across two projects. The project involves a commercial pilot in Cameron, Texas, with partners including Westinghouse, Halliburton, NAC International, Occlusion Nuclear Solutions, Amentum, and the Deep Borehole Demonstration Center. However, selection does not guarantee funding, as DOE may cancel negotiations at any time, and there is no assurance of a contract, funding amount, or successful completion of deliverables.

• ·Westinghouse will serve as launch customer to secure NRC certification for UCS with eVinci™ microreactor spent fuel.
• ·Project aligns with Executive Order 14302 on U.S. nuclear energy leadership and permanent spent fuel solutions.
• ·UCS developed through prior three-year DOE ARPA-E funded project.

08-04-2026

Delta Air Lines reported record adjusted operating revenue of $14.2 billion for the March Quarter 2026, up 9.4% YoY from $12.978 billion, driven by broad demand strength including premium revenue +14%, loyalty +13%, and record corporate sales with double-digit growth. Adjusted pre-tax income increased 42% to $532 million with EPS of $0.64, though GAAP results showed a pre-tax loss of $214 million and operating margin declined to 3.2%; non-fuel CASM rose 6% YoY while adjusted fuel expense increased 8% to $2.6 billion. For the June quarter, guidance projects low-teens revenue growth on flat capacity, 6-8% operating margin, $1.00-$1.50 EPS, and ~$1 billion pre-tax profit despite a $2 billion fuel expense increase and $4.30/gallon all-in fuel price.

• ·MRO revenue increased by more than $200 million YoY.
• ·Refinery benefit of approximately $300 million in June quarter guidance.
• ·Main cabin capacity contracted 3% YoY in March quarter.
• ·Ranked North America’s most on-time airline by Cirium for fifth consecutive year.
• ·Payments on debt and finance lease obligations of $1.6 billion in March quarter.

08-04-2026

Brookfield Asset Management Ltd. filed a Form 8-K on April 8, 2026, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), announcing the issuance of a press release dated April 8, 2026, attached as Exhibit 99.1. The filing contains no specific financial or operational details from the press release itself. It was signed by Kathy Sarpash, Managing Director, Legal & Regulatory and Corporate Secretary.

• ·Securities registered: Class A Limited Voting Shares (BAM) on New York Stock Exchange
• ·Commission File Number: 001-41563
• ·I.R.S. Employer Identification No.: 98-1702516
• ·Principal Executive Offices: 225 Liberty Street, 8th Floor, New York, New York 10281-1048

08-04-2026

Regeneron Pharmaceuticals expects an acquired in-process research and development (IPR&D) charge of approximately $102 million on a pre-tax basis for the first quarter 2026 (ended March 31, 2026), negatively impacting both GAAP and non-GAAP net income per diluted share by approximately $0.81. This charge primarily relates to premiums on equity securities purchased, as well as development milestone and up-front payments tied to collaboration and licensing agreements. The results are preliminary, unaudited, and subject to change following financial closing procedures.

• ·Regeneron does not forecast acquired IPR&D charges due to uncertainty in occurrence, magnitude, and timing.
• ·Acquired IPR&D charges may include those from asset acquisitions, up-front/opt-in payments, certain development milestones, and premiums on equity securities in collaborations/licensing.
• ·Information is not deemed 'filed' under Section 18 of the Exchange Act or automatically incorporated by reference.

08-04-2026

Stephens Group Asset Management, LLC filed its 13F-HR report disclosing $1,568,844,869 in total holdings as of March 31, 2026, invested primarily in ETFs from iShares, Vanguard, Schwab, and SPDR, with a focus on US equity value/growth, mid/small cap, international markets, and short-term treasuries/TIPS. Top holdings include Vanguard Index Fds Mcap Vl Idx Vip at $225,031,495, Vanguard Index Fds Value ETF at $193,272,500, and iShares Tr Rus Mdcp Val ETF at $103,982,727, all held solely. No changes in ownership or voting authority reported.

• ·Filing date: April 08, 2026
• ·Report period end: March 31, 2026
• ·Filer CIK: 0001726808
• ·All 26 positions held as sole ownership with 0 SH PRN and 0 SH VPN reported
• ·Business address: 100 River Bluff Drive, Suite 220, Little Rock, AR 72202

08-04-2026

ImmuCell Corporation announced preliminary, unaudited Q1 2026 product sales of $10.4 million, a 28.4% increase YoY from $8.1 million, driven by strong domestic sales growth to $9.7 million (+35.7%) and Tri-Shield® sales to $7.9 million (+38.5%). However, international sales declined 30.2% to $0.6 million, while Dual Force® & Other sales grew modestly 4.4% to $2.5 million. Management expressed confidence in strategy amid resolved backorders and new hires for sales expansion.

• ·Conference call scheduled for May 15, 2026 at 9:00 AM ET to discuss Q1 2026 financial results.
• ·Hired a leader for international commercial efforts and two domestic field sales managers.
• ·Previous production backorders continue to impact growth rate predictions.

08-04-2026

On April 7, 2026, Genesco Inc.'s Board of Directors adopted the Short-Term Incentive Plan (STIP), effective for the 2027 fiscal year, replacing the Fourth Amended and Restated EVA Plan. The STIP offers annual cash awards to eligible employees, including named executive officers, based on 75% business unit/corporate performance metrics and 25% individual strategic objectives, with multiples up to 3x target awards subject to Committee discretion and reductions. No specific performance outcomes or financial impacts are reported in the filing.

• ·Awards payable in cash, subject to clawback/recoupment policies and cancellation for unsatisfactory performance or policy violations.
• ·Committee approves target performance goals prior to April 30 each plan year; retains discretion to reduce (but not increase) bonuses.
• ·Performance criteria may include net earnings, EPS, revenue, operating income, cash flow, and others.

08-04-2026

Cadent Capital Advisors, LLC filed its quarterly 13F-HR on April 8, 2026, disclosing a portfolio valued at $386,499,179 across 201 holdings as of March 31, 2026. Top positions include Invesco Exchange Traded Fund Trust II S&P 500 Revenue ETF ($19,439,717; 169,173 shares), iShares Trust U.S. Aerospace & Defense ETF ($18,756,516; 85,744 shares), and Apple Inc. ($13,823,271; 54,467 shares). No prior period data is provided in the filing for comparison.

• ·Filing covers period ending 03-31-2026 with 3 other managers listed.
• ·Predominantly sole ownership; some defined (DFND) positions in Apple, Amazon, Microsoft, NVIDIA.
• ·Heavy allocation to ETFs (e.g., iShares, Invesco, Vanguard, SPDR series) and energy/MLPs (e.g., ONEOK Inc. 92473 shares, Kayne Anderson Energy Infrastructure 680307 shares).

08-04-2026

On April 8, 2026, Phio Pharmaceuticals Corp. entered into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC, enabling the company to offer and sell up to $6,360,000 of its common stock, par value $0.0001 per share, from time to time through the sales agent. The sales agent is entitled to a 3.0% commission on gross proceeds and reimbursement of up to $75,000 for legal counsel fees. No shares are obligated to be sold, and the agreement can be suspended or terminated at the company's discretion.

• ·Sales Agreement registered under Securities Act pursuant to shelf registration effective July 1, 2024
• ·Prospectus supplement filed with SEC on April 8, 2026
• ·Company's principal executive offices at 411 Swedeland Road, Suite 23-1080, King of Prussia, PA 19406
• ·Common Stock traded on The Nasdaq Capital Market under symbol PHIO

08-04-2026

Bausch Health Companies Inc. filed a DEFA14A Definitive Additional Materials proxy statement with the SEC on April 08, 2026. The filing is by the registrant with no fee required and no confidential treatment requested. No specific proposals, financial data, or substantive details are included in the provided filing header.

08-04-2026

Gilman Hill Asset Management, LLC filed its 13F-HR on April 08, 2026, disclosing equity holdings as of March 31, 2026, totaling $662,541,541 across 225 positions, all with sole voting authority. Notable holdings include Bristol-Myers Squibb ($13,951,855), Clearway Energy Inc. Class A ($12,106,624), Pfizer Inc. ($11,625,626), Sabra Health Care REIT Inc. ($11,598,964), and Flex LNG Ltd ($11,053,726). No prior period comparisons are available in this filing.

• ·Filing period end date: 2026-03-31
• ·All positions reported with sole voting authority
• ·No other investment managers listed

08-04-2026

MacroGenics, Inc. (MGNX) filed a DEFA14A Definitive Additional Materials proxy statement with the SEC on April 08, 2026. The filing was made by the registrant with no fee required.

• ·Filing type: DEFA14A (Schedule 14A Information Proxy Statement Amendment)

08-04-2026

Angel Studios, Inc. (ANGX) has filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Shareholders, to be held virtually on May 21, 2026, at 11:00 AM Mountain Time. Key proposals include electing five directors and ratifying the appointment of Tanner LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with the Board recommending a 'FOR' vote on both. Proxy materials, including the 2026 Proxy Statement and Annual Report for the year ended December 31, 2025, are available online at https://event.accessnewswire.com/angx-2025.

• ·Shareholders can request paper copies of proxy materials by May 11, 2026, via phone (1-888-266-6791) or email (proxy@continentalstock.com).
• ·Company address: 295 W Center St., Provo, UT 84601.
• ·Voting available online at www.cstproxyvote.com using control number.

08-04-2026

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company, filed an S-1 registration statement for its IPO on April 8, 2026, to list voting common stock under the Nasdaq symbol 'AVLN', with 483,842,421 shares outstanding immediately after the offering based on December 31, 2025 data post preferred stock conversion. The company reported net losses widening to $85.2 million in 2025 from $49.7 million in 2024 (71% YoY increase in loss magnitude), driven by R&D expenses rising 67% to $76.6 million and G&A up 29% to $14.7 million, though other income declined 17% to $6.1 million; cash, cash equivalents, and marketable securities stood at $138.4 million as of year-end. Net proceeds from the IPO (estimated at $ million at midpoint price) will fund clinical development of AP01 and AP02, preclinical AP03, additional R&D, and working capital.

• ·Accumulated deficit of $265.4 million as of December 31, 2025 (up from $180.2 million as of December 31, 2024).
• ·Total assets $148.9 million and working capital $129.5 million as of December 31, 2025.
• ·Underwriters' option to purchase up to additional shares within 30 days post-offering.
• ·$15.0 million in borrowings under Term Loan Facility entered February 2026.

08-04-2026

Moulton Wealth Management, Inc. filed its 13F-HR on April 8, 2026, disclosing 52 equity holdings as of March 31, 2026, with a total portfolio value of $146,894,843. All positions are held solely with no shared or other ownership reported, and no put/call options indicated. Largest holdings include Schwab Strategic Trust Government Money (4,610,837 shares), iShares iBonds Treasury Floating Rate Bond ETF (461,402 shares), and WisdomTree Floating Rate Treasury Fund (455,153 shares), focused heavily on bond ETFs, money market funds, and commodity/equity ETFs.

• ·No changes, additions, or deletions reported in holdings summary (indicated by '0' in filing header).
• ·Portfolio heavily weighted toward fixed income, floating rate bonds, money market funds, and commodity/miners ETFs.
• ·All 52 positions reported as SOLE ownership with zero shared, other, or options.

08-04-2026

East West Bancorp, Inc. filed its definitive proxy statement (DEF 14A) on April 8, 2026, for the virtual-only 2026 Annual Meeting of Stockholders on May 18, 2026 (record date March 30, 2026), proposing the election of 11 directors, an advisory vote to approve 2025 named executive officer compensation, amendment and restatement of the 2021 Stock Incentive Plan, adoption of the Employee Stock Purchase Plan, and ratification of KPMG LLP as independent auditors for the year ending December 31, 2026. The statement references the 2025 Annual Report on Form 10-K but provides no specific financial metrics or period-over-period comparisons in the excerpt. No declines, flat performance, or mixed results are highlighted as the focus is on governance matters.

• ·Annual Meeting: Monday, May 18, 2026, at 2:00 p.m. Pacific Time, virtual format via meetnow.global/MLUSZFD
• ·Proxy materials mailed on or about April 8, 2026; available at www.envisionreports.com/EWBC
• ·Fiscal year end: December 31
• ·Principal executive office: 135 N. Los Robles Ave., 7th Floor, Pasadena, CA 91101

08-04-2026

Ardent Health, Inc. (ARDT) has filed a definitive proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on May 20, 2026, at 9:00 a.m. Central Time. Key proposals include electing 11 director nominees, an advisory vote to approve named executive officer compensation, and ratification of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026. The record date is March 26, 2026, with 143,095,662 shares of common stock outstanding.

• ·Annual Meeting held solely by remote communication via live webcast at www.virtualshareholdermeeting.com/ARDT2026
• ·Voting prior to meeting available at www.proxyvote.com
• ·Company address: 340 Seven Springs Way, Suite 100, Brentwood, Tennessee 37027
• ·References 2025 Annual Report to Stockholders

08-04-2026

Brookdale Senior Living reported March 2026 consolidated weighted average occupancy of 82.0%, up 250 basis points YoY from 79.5%, while first quarter weighted average occupancy grew 280 basis points YoY to 82.1%. However, first quarter occupancy seasonally declined 40 basis points sequentially from the prior quarter, compared to a historical average decline of 60 basis points. Same community March weighted average occupancy improved 130 basis points YoY to 82.5%, with month-end occupancy rising sequentially to 83.3%.

• ·Consolidated month-end occupancy for March 2026: 83.3%
• ·Historically, Brookdale’s first quarter occupancy declines by an average of 60 basis points from prior quarter
• ·Brookdale operates in 41 states

08-04-2026

U.S. Bancorp announced changes to its Consolidated Statement of Income and Balance Sheet presentation effective January 1, 2026, including reclassifications of fee revenues (e.g., corporate payment products renamed and expanded, service charges renamed to lending and deposit-related fees) and loan portfolios (e.g., small business credit card loans moved to credit card portfolio), with no impact on total net revenues, net income, total loans, total assets, ROA, ROE, or EPS. The Impact Finance business unit was shifted to the Wealth, Corporate, Commercial and Institutional Banking segment. Unaudited supplemental historical financial information conforming to the new presentation is furnished in Exhibit 99.1.

• ·Changes apply to historical periods with conforming supplemental data in Exhibit 99.1, furnished under Item 7.01 and not deemed 'filed' under Section 18.
• ·Reclassifications align reporting with business management across segments including Payment Services, Consumer and Business Banking, and Wealth, Corporate, Commercial and Institutional Banking.

08-04-2026

Mirum Pharmaceuticals, Inc. completed the acquisition of Bluejay Therapeutics, Inc. on January 23, 2026, pursuant to a Merger Agreement dated December 6, 2025, making Bluejay a wholly owned subsidiary through a two-step merger process. Immediately following the acquisition, the company raised aggregate gross proceeds of approximately $268.5 million via a PIPE private placement of 3,385,149 shares of common stock at $68.48 per share and pre-funded warrants to purchase 536,412 shares at $68.4799 each. This 8-K/A amends the original filing to include Bluejay's audited financial statements for the year ended December 31, 2025, and unaudited pro forma condensed combined financial information as of and for the year ended December 31, 2025.

• ·Original 8-K filed on January 26, 2026
• ·Audited financial statements of Bluejay as of and for the year ended December 31, 2025 (Exhibit 99.1)
• ·Unaudited pro forma condensed combined balance sheet as of December 31, 2025, and statements of operations for the year ended December 31, 2025 (Exhibit 99.2)

08-04-2026

Pioneer Wealth Management Group filed its 13F-HR disclosing 50 equity positions held as of March 31, 2026, with a total market value of $356,532,100,000. The portfolio is heavily weighted toward ETFs, including top holdings in Dimensional ETF Trust US Core Equity Market ETF ($73,573,198,000), Schwab Strategic Trust US Aggregate Bond ETF ($46,435,369,000), and Dimensional ETF Trust Emerging Markets Core Equity Management ETF ($22,438,556,000), alongside stocks such as Apple Inc ($1,702,383,000) and Nvidia Corporation ($842,682,000). All positions are held solely with sole investment discretion and no voting authority shared.

• ·Report period end date: March 31, 2026
• ·Filing date: April 08, 2026
• ·All holdings reported with sole ownership and zero shared voting or performance rights
• ·Firm address: 800 W 5th St. Suite 100, Austin, TX 78703

08-04-2026

WLTH Capital Management, LLC filed its 13F-HR report for the quarter ended March 31, 2026, disclosing holdings in 25 ETF positions with a focus on diversified equity, fixed income, international, and emerging market funds from providers including iShares, SPDR, Vanguard, and Schwab. The largest position is in Vanguard Scottsdale Fds Long Term Treasuries valued at $14,039,968,000, followed by Invesco Exchange Traded Self Idx Fd Bulshs 2026 CB at $7,107,455,000. Other notable holdings include iShares Core S&P Small-Cap ETF at $6,822,876,000 and SPDR Index Shs Fds at $4,221,449,000.

08-04-2026

Bitcoin Depot Inc. disclosed a material cybersecurity incident discovered on March 23, 2026, in which an unauthorized party accessed systems and transferred approximately 50.903 Bitcoin valued at $3.665 million from company-controlled wallets. The breach was contained to corporate environments, with no evidence of customer data access or impact on customer platforms, and no material effect on operations as of the filing date. However, the company recorded a preliminary loss of $3.665 million and noted potential risks including reputation harm, legal, regulatory, and response costs, with insurance coverage that may offset losses but is not assured.

• ·Incident reported under Item 1.05 as material due to potential consequences despite no current material operational impact.
• ·Company engaged external cybersecurity experts and notified law enforcement; remediation efforts ongoing.
• ·Investigation continues; company may amend the 8-K if additional information becomes available.
• ·Warrants exercisable at $80.50 per share of Class A Common Stock.

08-04-2026

StoneCrest Wealth Management, Inc. filed a 13F-HR disclosing $236,393,826 in equity holdings across 73 positions as of March 31, 2026. The portfolio is concentrated in ETFs and technology stocks, with top holdings including Invesco NASDAQ 100 ETF at $16,708,963 (70,318 shares), NVIDIA Corporation at $13,655,869 (78,302 shares), and Invesco S&P Intl Momentum ETF at $12,366,859 (225,508 shares). No changes in voting authority were reported, all held as sole.

• ·Filing date: April 8, 2026
• ·Report period end: March 31, 2026
• ·All holdings reported with sole voting authority (SH SOLE)

08-04-2026

Cardinal Capital Management, based in Raleigh, NC, filed its 13F-HR report on April 8, 2026, disclosing 136 equity holdings totaling $775631165 as of March 31, 2026. All positions are held with sole discretionary voting authority, with top holdings including Johnson & Johnson (28448118 value), Eli Lilly & Co (24642819), Apple Inc (22083261), Exxon Mobil Corp (19579443), and Walmart Inc (19296149). No prior period data is provided in the filing for comparison.

• ·Filing period end date: March 31, 2026
• ·All 136 holdings reported with sole voting authority (SH SOLE); no shared or other authority positions
• ·Firm CIK: 0001434845; SEC file number: 028-13067

08-04-2026

Pines Wealth Management, LLC filed its 13F-HR report disclosing 215 equity positions with a total market value of $308,952,869 as of March 31, 2026. Top holdings include NVIDIA Corporation ($11,124,161), Apple Inc ($10,155,153), and Microsoft Corp ($8,266,689), all under sole voting authority. No changes or prior period comparisons are indicated in the filing.

• ·Filing date: April 08, 2026
• ·Report period end: March 31, 2026
• ·All positions reported with sole voting authority and no shared or other voting authority

08-04-2026

Catalyst Bancorp, Inc. (Nasdaq: CLST) announced a definitive agreement to acquire Lakeside Bancshares, Inc. (OTC: LKSB) in an all-cash transaction for $41.1 million, or $19.58 per share, which will merge Lakeside Bank into Catalyst Bank. The acquisition more than doubles Catalyst's size based on December 31, 2025 data, resulting in combined assets of $627.3 million, loans of $399.9 million, and deposits of $470.0 million, and is expected to be over 180% accretive to EPS once cost savings are realized, with accretiveness to tangible book value per share within 3 years. The deal, unanimously approved by both boards, is anticipated to close in Q3 2026 subject to regulatory and shareholder approvals, with no additional capital needed and strong post-merger capital ratios of 10.4% leverage and 15.4% total risk-based.

• ·Transaction unanimously approved by boards of both companies.
• ·Post-merger capital position: leverage ratio approximately 10.4%, total risk-based capital ratio 15.4%.
• ·No additional capital required by Catalyst to complete the transaction.
• ·Lakeside Bank began operations July 10, 2010; holding company formed February 2018.

08-04-2026

Genco Shipping & Trading Ltd (GNK) filed a DEFA14A additional proxy soliciting materials on April 8, 2026, in connection with the 2026 Annual Meeting of Shareholders, disclosing participants including independent directors Paramita Das, Kathleen C. Haines, Basil G. Mavroleon, Karin Y. Orsel, Arthur L. Regan, and executives John C. Wobensmith (Chairman, CEO, President), Peter Allen (CFO), Joseph Adamo (Chief Accounting Officer), and Jesper Christensen (Chief Commercial Officer). The filing references prior proxy statement from April 9, 2025, and multiple Form 4 filings detailing participants' security holdings changes. Shareholders are urged to review the forthcoming definitive proxy statement and white proxy card on SEC's website or the company's investor relations site at https://investors.gencoshipping.com/.

• ·References Form 4 filings for ownership changes: multiple dates in 2025 (May 22, June 3, August 26, September 10, September 15, November 12, November 26) and 2026 (February 18, February 23, March 20).
• ·Prior proxy statement filed April 9, 2025, covers director compensation, CD&A, summary comp table, and security ownership.
• ·Discusses factors affecting dividends: credit agreements, Marshall Islands law, board review of financials, market, cash flows, capex.

08-04-2026

Global Medical REIT Inc. (GMRE-PB) filed a DEFA14A on April 08, 2026, providing notice of internet availability of proxy materials for its 2026 Annual Meeting. Shareholders can access materials online at https://web.viewproxy.com/XRN/2026, request paper or email copies by May 12, 2026 at no charge, or vote via internet at https://www.AALvote.com/XRN using their 11-digit Control Number prior to or during the virtual meeting. The filing emphasizes SEC rules allowing electronic delivery of proxy materials.

• ·11-digit Control Number required for accessing materials, virtual attendance, and voting
• ·Telephone request line: 1-877-777-2857 (toll free)
• ·Email requests: requests@viewproxy.com with company name and Control Number in subject line